Retraction
MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5
Paper Information
Record ID:
37828
Author(s):
Journal:
Publication Date:
June 15, 2019
Retraction Date:
June 18, 2022
(3.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations1
Post-Retraction(7.7%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
578
Days since retraction (latest)
ZIC1 inhibits the growth of glioblastoma cell U87MG by enhancing CUL5 expression
Yanna Li, Jiao Li, Weiyi Zhan et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jan 2024
578 days after retraction
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine
Amoolya Kandettu, Divya Adiga, Vasudha Devi et al. (7 authors)
Genes & Diseases
Open Access
Published: Mar 2022
15 citations
15 citations
109 days before retraction
Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors
Zian Li, Nan Hu, Lirui Dai et al. (7 authors)
Bioengineered
Open Access
Published: Jan 2021
11 citations
11 citations
533 days before retraction
Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma
Yunxia Liu, Xia Liu, Yanhua Zhou et al. (5 authors)
Clinical and Experimental Medicine
Published: Aug 2020
6 citations
6 citations
667 days before retraction
The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions
Chen Seraya-Bareket, Avivit Weisz, Elena Shinderman‐Maman et al. (12 authors)
Oncogenesis
Open Access
Published: Jul 2020
14 citations
14 citations
689 days before retraction
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Ali A. Alshamrani
Frontiers in Oncology
Open Access
Published: Jul 2020
77 citations
77 citations
697 days before retraction
The role of microRNA in cisplatin resistance or sensitivity
Shanshan Wang, Mingyue Li, Yi Liu et al. (16 authors)
Expert Opinion on Therapeutic Targets
Published: Jun 2020
38 citations
38 citations
729 days before retraction
Cullin-RING Ligase 5: Functional characterization and its role in human cancers
Yongchao Zhao, Xiufang Xiong, Yi Sun
Seminars in Cancer Biology
Open Access
Published: Apr 2020
58 citations
58 citations
787 days before retraction
Inhibitory effect of dihydromyricetin on the proliferation of JAR cells and its mechanism of action
Yanzhen Zuo, Yanjie Lu, Qian Xu et al. (7 authors)
Oncology Letters
Open Access
Published: Apr 2020
20 citations
20 citations
793 days before retraction
Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer
Lanlan Feng, Fangrong Shen, Jinhua Zhou et al. (6 authors)
Bioscience Reports
Open Access
Published: Mar 2020
19 citations
19 citations
821 days before retraction
Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway
Yanling Guo, Zhenxing Zhang, Zhaoxia Wang et al. (6 authors)
Bioscience Reports
Open Access
Published: Mar 2020
45 citations
45 citations
839 days before retraction
The functions and properties of cullin-5, a potential therapeutic target for cancers.
Feng Gao, Yimin Fan, Bolun Zhou et al. (7 authors)
PubMed
Published: Jan 2020
15 citations
15 citations
899 days before retraction
Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
Alka Singh, Sameer Gupta, Manisha Sachan
Frontiers in Cell and Developmental Biology
Open Access
Published: Sep 2019
74 citations
74 citations
1003 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
3.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025